Literature DB >> 17707895

Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.

Karin C H M Bisseling1, Ruud L M Bekkers, Rob M Rome, Michael A Quinn.   

Abstract

OBJECTIVE: To investigate the efficacy of different treatment modalities used in microinvasive adenocarcinoma (AC) of the uterine cervix (FIGO stage IA1 and IA2), and review the literature.
METHODS: Medical and histopathological records of 38 patients treated for microinvasive AC of the cervix were studied retrospectively, and compared with the literature.
RESULTS: Twenty-nine patients had stage IA1 and nine stage IA2 cancers. Treatment modalities ranged from radical hysterectomy with pelvic lymph node dissection (PLND) to conization only. Eighteen patients underwent a conization, including two patients with stage IA2 disease, of whom 11 had 18 pregnancies in total, resulting in 13 live births, two terminations and three spontaneous abortions. In two patients a hysterectomy was performed after pregnancy. No recurrences were noted during an average follow-up of 72 months. In the literature 1565 patients were reported. Of the 814 patients undergoing PLND, 12 had positive nodes. Lymphovascular space invasion (LVSI) was present in 25 patients, all without node involvement. None of the 356 described parametria were involved. Twenty-nine recurrences occurred. In total, 21 pregnancies with 16 live births occurred in those patients treated to preserve fertility.
CONCLUSIONS: There is no uniformity in the treatment of microinvasive AC of the uterine cervix. For stage IA1 disease, conization seems to be safe and PLND is only recommended where LVSI is present. Although the number of reported cases is small, for stage IA2 disease, conization with PLND in case of LVSI seems advisable. More studies are desirable to define the optimal treatment for patients with microinvasive AC of the cervix, especially with regard to those patients with stage IA2 disease.

Entities:  

Mesh:

Year:  2007        PMID: 17707895     DOI: 10.1016/j.ygyno.2007.07.062

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  17 in total

1.  New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.

Authors:  Andres A Roma; Toni-Ann Mistretta; Andrea Diaz De Vivar; Kay J Park; Isabel Alvarado-Cabrero; Golnar Rasty; Jose G Chanona-Vilchis; Yoshiki Mikami; Sung R Hong; Norihiro Teramoto; Rouba Ali-Fehmi; Denise Barbuto; Joanne K L Rutgers; Elvio G Silva
Journal:  Gynecol Oncol       Date:  2016-04       Impact factor: 5.482

Review 2.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

Review 3.  Human Papillomavirus in Kidney Transplant Recipients.

Authors:  Peter V Chin-Hong
Journal:  Semin Nephrol       Date:  2016-09       Impact factor: 5.299

4.  Pattern classification of endocervical adenocarcinoma: reproducibility and review of criteria.

Authors:  Joanne K L Rutgers; Andres A Roma; Kay J Park; Richard J Zaino; Abbey Johnson; Isabel Alvarado; Dean Daya; Golnar Rasty; Teri A Longacre; Brigitte M Ronnett; Elvio G Silva
Journal:  Mod Pathol       Date:  2016-06-03       Impact factor: 7.842

Review 5.  Fertility-Sparing Options in Young Women with Cervical Cancer.

Authors:  Federica Tomao; Giacomo Corrado; Fedro Alessandro Peccatori; Sara Boveri; Eleonora Petra Preti; Nicoletta Colombo; Fabio Landoni
Journal:  Curr Treat Options Oncol       Date:  2016-01

6.  Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix.

Authors:  Isao Murakami; Takuma Fujii; Kaori Kameyama; Takashi Iwata; Miyuki Saito; Kaneyuki Kubushiro; Daisuke Aoki
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

7.  Conservative Treatment of Stage IA1 Adenocarcinoma of the Uterine Cervix during Pregnancy: Case Report and Review of the Literature.

Authors:  Francesco Sopracordevole; Diego Rossi; Jacopo Di Giuseppe; Marta Angelini; Pierino Boschian-Bailo; Monica Buttignol; Andrea Ciavattini
Journal:  Case Rep Obstet Gynecol       Date:  2014-03-16

8.  Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China.

Authors:  Qiuhong Qian; Jiaxin Yang; Dongyan Cao; Yan You; Jie Chen; Keng Shen
Journal:  J Gynecol Oncol       Date:  2014-06-18       Impact factor: 4.401

9.  Fertility-preserving surgery in patients with early stage cervical carcinoma.

Authors:  Spyridon Kardakis
Journal:  ISRN Oncol       Date:  2012-12-18

10.  Fertility-sparing surgery for early-stage cervical cancer.

Authors:  Adelaide Fernanda Ribeiro Cubal; Joana Isabel Ferreira Carvalho; Maria Fernanda Martins Costa; Ana Paula Tavares Branco
Journal:  Int J Surg Oncol       Date:  2012-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.